CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Charlie's Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026

$0.11+0.01 (+13.30%)

Close on Oct 19, 2026

Market cap: $31.05M
P/E (TTM): –
Dividend yield: –

Dividends

Charlie's has not reported a dividend

No dividend per share appears in Charlie's's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Charlie's's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-100 reverse split on Aug 16, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CHUC.

Revenue growth310.5% · median -4.5%

Gross margin27.4% · median 48.7%

Operating margin-10.8% · median -21.9%

Net margin-7.9% · median -32.0%

Company	Revenue	Growth
SNYRQ	$27.70M	-17.5%
CYAN	$25.27M	+8.5%
CHUC	$24.67M	+310.5%
BON	–	–
LEEEF	–	–
CWLXF	–	–

Company

Exchange: OTC
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: December 31
Employees: 35
Held by institutions: 0.0%
Auditor: Urish Popeck & Co., LLC
SEC CIK: 1134765

Advertisement
300 × 250